Cargando…

Identification of prognostic alternative splicing signature in gastric cancer

BACKGROUND: Aberrant alternative splicing (AS) events could be viewed as prognostic indicators in a large number of malignancies. This study aims to identify prognostic AS events, illuminate the function of the splicing variants biomarkers and provide reliable evidence for formulating public health...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhiwu, Wu, Qiong, Liu, Yankun, Li, Qingke, Li, Jingwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131537/ https://www.ncbi.nlm.nih.gov/pubmed/35614517 http://dx.doi.org/10.1186/s13690-022-00894-3

Ejemplares similares

Development and validation of an individual alternative splicing prognostic signature in gastric cancer
por: Lou, Shenghan, et al.
Publicado: (2021)

Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer
por: Huang, Runzhi, et al.
Publicado: (2021)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Immunological significance of alternative splicing prognostic signatures for bladder cancer
por: Li, Xinyun, et al.
Publicado: (2022)

Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma
por: Zhu, Jiwen, et al.
Publicado: (2023)

Identification of prognostic and bone metastasis‐related alternative splicing signatures in mesothelioma
por: Huang, Runzhi, et al.
Publicado: (2021)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
por: Chen, Peigen, et al.
Publicado: (2020)

Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
por: Ouyang, Dong, et al.
Publicado: (2020)

Characterization of alternative splicing events and prognostic signatures in breast cancer
por: Han, Pihua, et al.
Publicado: (2021)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer
por: Zong, Zhen, et al.
Publicado: (2018)

Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer
por: Hu, Yue-Xin, et al.
Publicado: (2019)

Prognostic alternative splicing signature reveals the landscape of immune infiltration in Pancreatic Cancer
por: Wang, Lin, et al.
Publicado: (2020)

Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma
por: Zhao, Xinyuan, et al.
Publicado: (2020)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer
por: Liu, Yunze, et al.
Publicado: (2022)

Identification of an alternative splicing signature as an independent factor in colon cancer
por: Chen, Haitao, et al.
Publicado: (2020)

Identification of prognostic alternative splicing events in sarcoma
por: Li, Hongshuai, et al.
Publicado: (2021)

Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
por: Meng, Tong, et al.
Publicado: (2019)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Prognostic significance of survival-associated alternative splicing events in gastric cancer
por: Zhang, Shichao, et al.
Publicado: (2020)

Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression
por: Feng, Haoran, et al.
Publicado: (2020)

Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia
por: Jin, Peng, et al.
Publicado: (2020)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Alternative splicing signatures in preimplantation embryo development
por: Tian, Geng G., et al.
Publicado: (2020)

Screening Gene Expression-Related Alternative Splicing Event Signature for Colon Cancer Prognostic Prediction
por: Xu, Jie, et al.
Publicado: (2022)

Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer
por: Zhao, Jiyu, et al.
Publicado: (2020)

Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases
por: Cheng, Xiaohu, et al.
Publicado: (2020)

Metabolism reprogramming signature associated with stromal cells abundance in tumor microenvironment improve prognostic risk classification for gastric cancer
por: Huo, Junyu, et al.
Publicado: (2022)

Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma
por: Chang, Ya-Sian, et al.
Publicado: (2020)

Identification of the prognostic signature based on genomic instability-related alternative splicing in colorectal cancer and its regulatory network
por: Ding, Qiuying, et al.
Publicado: (2022)

Systematic analysis of survival‐associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer
por: Liang, Ying, et al.
Publicado: (2019)

Prognostic values of tissue factor and its alternatively splice transcripts in human gastric cancer tissues
por: Wu, Min, et al.
Publicado: (2017)

The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma
por: Huang, Runzhi, et al.
Publicado: (2022)

An alternative splicing signature in human Crohn’s disease
por: Li, Daowei, et al.
Publicado: (2021)

Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hd4ncsno7pu2oifi4ltknecpfr